Trial Profile
A Pilot Study of Flumist, a Live Attenuated Intranasal Influenza Vaccine, and Inactivated Influenza Vaccine in Children With Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms FMRESP
- 23 Sep 2011 Results published in the Journal of Infectious Diseases.
- 23 Sep 2011 Primary endpoint 'Haemagglutin-inhibition-antibody-levels' has been met.
- 23 Sep 2011 Primary endpoint 'Immunological-response' has been met.